Vestal Point Capital »

Newamsterdam Pharma Co Nv shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $480k 25k 19.21

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
RA Capital Management
Viking Global Investors
Medicxi Ventures Management
Cormorant Asset Management
Adage Capital Partners GP
BVF
Polar Capital Holdings
Millennium Management
Henderson Group
GMT Capital Corp
Jennison Associates
Deerfield Management Company

View all funds holding Newamsterdam Pharma Co Nv